DOT Drug Testing & Safety-Sensitive Jobs

Beginning January 1, 2018, in addition to the existing DOT drug testing panel (that includes marijuana, cocaine, amphetamines, phencyclidine (PCP), and opiates), you will also be tested for four semi-synthetic opioids (i.e., hydrocodone, oxycodone, hydromorphone, oxymorphone). 

DOT Drug Testing

Employees

Testing positive for any of the semi-synthetic opioid drugs, as with any other drug test result that is confirmed by the laboratory, requires the Medical Review Officer (MRO) to conduct an interview with you to determine whether there is a legitimate medical explanation for the result. If you have a valid prescription, say for migraines or arthritis pain, you need to provide it to the MRO, who will determine if the prescription is valid. If there is a legitimate medical explanation, the MRO will report the result to your employer as a negative. If not, the MRO will report the result to your employer as positive.

Removal From Safety-Sensitive Duties

As it has been the requirement for many years, when an employer receives a positive drug test result, they must immediately remove the offending employee from performing safety-sensitive functions and provide a list of qualified Substance Abuse Professionals (SAP) available in your area. In order to return to performing safety-sensitive functions for any DOT-regulated employer, the employee must complete the return-to-duty process that will include an evaluation by an SAP. They will determine if you’ve successfully completed the prescribed education and/or treatment. Before an employer could return you to safety-sensitive work, the employer must get a negative result on a directly observed return-to-duty drug test. After you return to safety-sensitive work, you must be subject to directly observed follow-up testing for 12-60 months depending on the SAP’s recommendations.

If your business is in need of a reliable drug testing program, please contact Test Smartly Labs today.

Speak Your Mind

*